Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses

Kevin G. Keegan Department of Veterinary Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211.

Search for other papers by Kevin G. Keegan in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
Nat T. Messer Department of Veterinary Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211.

Search for other papers by Nat T. Messer in
Current site
Google Scholar
PubMed
Close
 DVM
,
Shannon K. Reed Department of Veterinary Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211.

Search for other papers by Shannon K. Reed in
Current site
Google Scholar
PubMed
Close
 DVM
,
David A. Wilson Department of Veterinary Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211.

Search for other papers by David A. Wilson in
Current site
Google Scholar
PubMed
Close
 DVM, MS
, and
Joanne Kramer Department of Veterinary Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211.

Search for other papers by Joanne Kramer in
Current site
Google Scholar
PubMed
Close
 DVM

Abstract

Objective—To determine the effectiveness of administering multiple doses of phenylbutazone alone or a combination of phenylbutazone and flunixin meglumine to alleviate lameness in horses.

Animals—29 adult horses with naturally occurring forelimb and hind limb lameness.

Procedures—Lameness evaluations were performed by use of kinematic evaluation while horses were trotting on a treadmill. Lameness evaluations were performed before and 12 hours after administration of 2 nonsteroidal anti-inflammatory drug (NSAID) treatment regimens. Phenylbutazone paste was administered at approximately 2.2 mg/kg, PO, every 12 hours for 5 days, or phenylbutazone paste was administered at approximately 2.2 mg/kg, PO, every 12 hours for 5 days in combination with flunixin meglumine administered at 1.1 mg/kg, IV, every 12 hours for 5 days.

Results—Alleviation of lameness was greater after administration of the combination of NSAIDs than after oral administration of phenylbutazone alone. Improvement in horses after a combination of NSAIDs did not completely mask lameness. Five horses did not improve after either NSAID treatment regimen. All posttreatment plasma concentrations of NSAIDs were less than those currently allowed by the United States Equestrian Federation Inc for a single NSAID. One horse administered the combination NSAID regimen died of acute necrotizing colitis during the study.

Conclusions and Clinical Relevance—Administration of a combination of NSAIDs at the dosages and intervals used in the study reported here alleviated the lameness condition more effectively than did oral administration of phenylbutazone alone. This may attract use of combinations of NSAIDs to increase performance despite potential toxic adverse effects.

Abstract

Objective—To determine the effectiveness of administering multiple doses of phenylbutazone alone or a combination of phenylbutazone and flunixin meglumine to alleviate lameness in horses.

Animals—29 adult horses with naturally occurring forelimb and hind limb lameness.

Procedures—Lameness evaluations were performed by use of kinematic evaluation while horses were trotting on a treadmill. Lameness evaluations were performed before and 12 hours after administration of 2 nonsteroidal anti-inflammatory drug (NSAID) treatment regimens. Phenylbutazone paste was administered at approximately 2.2 mg/kg, PO, every 12 hours for 5 days, or phenylbutazone paste was administered at approximately 2.2 mg/kg, PO, every 12 hours for 5 days in combination with flunixin meglumine administered at 1.1 mg/kg, IV, every 12 hours for 5 days.

Results—Alleviation of lameness was greater after administration of the combination of NSAIDs than after oral administration of phenylbutazone alone. Improvement in horses after a combination of NSAIDs did not completely mask lameness. Five horses did not improve after either NSAID treatment regimen. All posttreatment plasma concentrations of NSAIDs were less than those currently allowed by the United States Equestrian Federation Inc for a single NSAID. One horse administered the combination NSAID regimen died of acute necrotizing colitis during the study.

Conclusions and Clinical Relevance—Administration of a combination of NSAIDs at the dosages and intervals used in the study reported here alleviated the lameness condition more effectively than did oral administration of phenylbutazone alone. This may attract use of combinations of NSAIDs to increase performance despite potential toxic adverse effects.

Contributor Notes

Dr. Reed's present address is Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97330.

Supported in part by the United States Equestrian Federation Incorporated and the E. Paige Laurie Endowed Program in Equine Lameness, University of Missouri, Columbia, Mo.

Address correspondence to Dr. Keegan.
  • 1.

    United States Equestrian Federation (USEF). Drugs and Medications Guidelines. August 1, 2007. Available at: http//www.usef.org/documents/competitions/2007/2007DrugsMedsGuidelines.pdf.

    • Search Google Scholar
    • Export Citation
  • 2.

    American Association of Equine Practitioners. Guide for veterinary service and judging of equestrian events. 4th ed. Lexington, Ky: American Association of Equine Practitioners, 1991.

    • Search Google Scholar
    • Export Citation
  • 3.

    Keegan KG, Pai PF, Wilson DA, et al. A curve-fitting technique for evaluating head movement to measure forelimb lameness in horses. Biomed Sci Instrum 2000;36:239244.

    • Search Google Scholar
    • Export Citation
  • 4.

    Kramer J, Keegan KG, Kelmer G, et al. Objective determination of pelvic movement during hind limb lameness using a signal decomposition method and pelvic height differences. Am J Vet Res 2004;65:741747.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Kelmer G, Keegan KG, Kramer J, et al. Computer-assisted kinematic evaluation of induced compensatory lameness in horses trotting on a treadmill. Am J Vet Res 2005;66:646655.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Lees P, Higgins AJ. Clinical pharmacology and therapeutic uses of non-steroidal anti-inflammatory drugs in the horse. Equine Vet J 1985;17:8396.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Semrad SD, Sams RA, Harris ON, et al. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares. Am J Vet Res 1993;54:19011905.

    • Search Google Scholar
    • Export Citation
  • 8.

    Tobin T, Chay S, Kamerling S, et al. Phenylbutazone in the horse: a review. J Vet Pharmacol Ther 1986;9:125.

  • 9.

    Chay S, Woods WE, Nugent T, et al. The pharmacology of nonsteroidal anti-inflammatory drugs in the horse: flunixin meglumine (Banamine). Equine Pract 1982;4:1623.

    • Search Google Scholar
    • Export Citation
  • 10.

    Higgins AJ, Lees P, Taylor JB. Influence of phenylbutazone on eicosanoid levels in equine acute inflammatory exudates. Cornell Vet 1984;74:198207.

    • Search Google Scholar
    • Export Citation
  • 11.

    Lees P, Higgins AJ. Flunixin inhibits prostaglandin E2 production in equine inflammation. Res Vet Sci 1984;37:347349.

  • 12.

    Lees P, Taylor JBO, Maitho TE, et al. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse. Cornell Vet 1987;77:192211.

    • Search Google Scholar
    • Export Citation
  • 13.

    Lees P, Taylor JBO, Higgins AJ, et al. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse. J Vet Pharmacol Ther 1986;9:204212.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Higgins AJ, Lees P, Taylor JBO, et al. Flunixin meglumine: quantitative determination in and effects on composition of equine inflammatory exudate. Br Vet J 1986;142:163169.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Raekallio M, Taylor PM, Bennett RC. Preliminary investigations of pain and analgesia assessment in horses administered phenylbutazone or placebo after arthroscopic surgery. Vet Surg 1997;26:150155.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Toutain PL, Autefage A, Legrand C, et al. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacolkinetic/pharmacodynamic modeling. J Vet Pharmacol Ther 1994;17:459469.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Erkert RS, MacAllister CG, Payton ME, et al. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome. Am J Vet Res 2005;66:284288.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Hu HH, MacAllister CG, Payton ME, et al. Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness. J Am Vet Med Assoc 2005;226:414417.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Soma LR, Gallis DE, Davis WL, et al. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration. Am J Vet Res 1983;44:21042109.

    • Search Google Scholar
    • Export Citation
  • 20.

    Maitho TE, Lees P, Taylor JB. Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies. J Vet Pharmacol Ther 1986;9:2639.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Toutain PL, Lassourd V. Pharmacokinetic/pharmacodynamic approach to assess irrelevant plasma or urine drug concentrations in postcompetition samples for drug control in the horse. Equine Vet J 2002;34:242249.

    • Search Google Scholar
    • Export Citation
  • 22.

    MacAllister CG, Morgan SJ, Borne AT, et al. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 1993;202:7177.

    • Search Google Scholar
    • Export Citation
  • 23.

    Houdeshell JW, Hennessey PW. A new nonsteroidal antiinflammatory analgesic for horses. J Equine Med Surg 1977;1:5763.

  • 24.

    Carrick JB, Papich MG, Middleton DM, et al. Clinical and pathological effects of flunixin meglumine administration to neonatal foals. Can J Vet Res 1989;53:195201.

    • Search Google Scholar
    • Export Citation
  • 25.

    Lees P, Creed CRS, Gerring EEL, et al. Biochemical and hematological effects of phenylbutazone in horses. Equine Vet J 1983;5:158167.

  • 26.

    Reed SK, Messer NT, Tessman RT, et al. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. Am J Vet Res 2006;67:398402.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement